Ron Cooper – Biography
Last update: February 11, 2026Executive profile
Ron was Director at Genocea Biosciences, and President, Europe at Bristol-Myers Squibb. Ron Cooper joined Generation Bio in 2024.
Ron Cooper is currentlyChief Executive Officer and Director at enGene Therapeutics - View - enGene Therapeutics org chart
Chairman of the Board at C4 Therapeutics - View - C4 Therapeutics org chart
Director at Generation Bio - View - Generation Bio org chart
Create your alert
to follow the career of Ron Cooper.
Education
Ron Cooper has a Masters of Health Administration in Health Care Administration from University of North Carolina at Chapel Hill and a Urology Residency Program from Stanford University.
They have also studied at University of North Carolina at Chapel Hill :
Find more alumni from University of North Carolina at Chapel Hill
They have also studied at Stanford University :
Find more alumni from Stanford University
More about Ron Cooper
Selected links
Do you need to know more about Ron Cooper? More results.
Participate
Social media
- Ron Cooper on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Ron Cooper
The colleagues of Ron Cooper
Company Colleagues
- At enGene Therapeutics, Ron Cooper has 26 colleagues including Richard Glickman (Chairman of the Board), Michael Heffernan (Director)…
- At C4 Therapeutics, Ron Cooper has 26 colleagues including Andrew Hirsch (CEO & Director), Utpal Koppikar (Director)…
- At Generation Bio, Ron Cooper has 18 colleagues including Yalonda Howze (Interim CEO & President), Charles Rowland (Director)…
Industry Colleagues
- In the Biotechnology industry, Ron Cooper has 35,757 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Ron Cooper.
